Sanofi Stock Euronext Paris
Stocks
SANNV
FR001400M6Z3
Pharmaceuticals
OTC Markets Traded| Market Cap | 90.95B 104B 83.82B 77.69B 147B 9,864B 150B 1,005B 391B 4,868B 390B 382B 16,827B | P/E 2026 * |
11.4x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 101B 115B 92.76B 85.98B 163B 10,916B 166B 1,112B 433B 5,387B 432B 422B 18,621B | EV / Sales 2026 * |
2.13x | EV / Sales 2027 * | 1.92x |
| Free-Float |
89% | Yield 2026 * |
5.61% | Yield 2027 * | 5.95% |
Last Transcript: Sanofi
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 64 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 104B | |
| -0.49% | +3.16% | +58.10% | +171.31% | 1,102B | |
| -0.27% | +4.89% | +71.00% | +67.01% | 643B | |
| +0.33% | +1.46% | +34.23% | +89.40% | 450B | |
| +1.02% | -0.30% | +29.05% | +25.11% | 336B | |
| -0.84% | +0.58% | +28.67% | +46.56% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.13% | 222B | |
| -0.05% | +1.87% | +23.94% | +63.80% | 199B | |
| -0.49% | +7.76% | +22.23% | +79.35% | 169B | |
| +0.93% | +1.70% | -5.21% | -31.94% | 137B | |
| Average | -0.12% | +2.00% | +25.98% | +52.39% | 393.9B | |
| Weighted average by Cap. | -0.21% | +1.86% | +40.80% | +86.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.19B 53.92B 43.49B 40.31B 76.52B 5,118B 77.75B 521B 203B 2,526B 202B 198B 8,730B | 50.26B 57.43B 46.32B 42.93B 81.49B 5,450B 82.81B 555B 216B 2,690B 216B 211B 9,297B |
| Net income | 7.8B 8.91B 7.18B 6.66B 12.64B 845B 12.84B 86.15B 33.5B 417B 33.44B 32.72B 1,442B | 8.62B 9.85B 7.95B 7.37B 13.98B 935B 14.21B 95.29B 37.06B 462B 37B 36.19B 1,595B |
| Net Debt | 9.7B 11.08B 8.94B 8.28B 15.73B 1,052B 15.98B 107B 41.68B 519B 41.61B 40.71B 1,794B | 5.6B 6.4B 5.16B 4.78B 9.08B 607B 9.22B 61.86B 24.05B 300B 24.01B 23.49B 1,036B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
